Simulations Plus (SLP) President Fiedler-Kelly Buys $11K of Stock

On June 15, 2026, Jill Fiedler-Kelly, President of Services Solutions at Simulations Plus, Inc. (NasdaqGS: SLP), purchased 1,050 shares of the company. The shares were acquired at an average price of $10.05, amounting to a total transaction value of $10,552.50.

Insider Buying and Selling at Simulations Plus, Inc.

Jill Fiedler-Kelly's recent purchase was not under a planned trading scheme, indicating a direct buy on the open market. This follows her earlier acquisition of 1,000 shares at the same price on May 11, 2026. Additionally, other insiders like John Anthony DiBella II and Walter Woltosz have executed planned sales in June 2026.

Other Institutional Activity in Simulations Plus

First Light Asset Management significantly boosted its position in Simulations Plus by adding 663,906 shares, bringing its total to 2,632,823 shares valued at approximately $31.1 million. In contrast, BlackRock, Inc. trimmed its holdings slightly by 4,296 shares, ending with 1,252,376 shares worth about $14.8 million. Morgan Stanley also reduced its stake by 112,638 shares, holding 887,511 shares valued at $10.5 million. Meanwhile, First Eagle Investment Management increased its position by 284,914 shares to 742,069 shares, worth around $8.8 million.

Simulations Plus, Inc. Stock Down 1.1%

Shares of Simulations Plus, Inc. are currently trading at $16.37. The company, which operates in the healthcare sector, has a market cap of $368.5 million and a forward P/E ratio of 19.96. The stock has experienced a 52-week range between $11.09 and $21.01. Simulations Plus maintains a strong liquidity position with a current ratio of 5.47 and a quick ratio of 5.26, alongside a low debt-to-equity ratio of 0.38.

Analysts Set New Price Targets

Analyst firm TD Cowen maintained a 'hold' rating on Simulations Plus with a price target of $16.0 on April 10, 2026. The consensus among analysts is a 'buy' recommendation, with a mean target price of $23.50 based on two analyst opinions.

About Simulations Plus, Inc.

Simulations Plus, Inc., headquartered in Research Triangle Park, North Carolina, develops software for drug discovery and development, utilizing AI and machine learning. The company operates through its Software and Services segments, offering products like GastroPlus and DDDPlus for pharmacokinetic modeling. Simulations Plus serves clients in the pharmaceutical, biotechnology, and other industries, providing consulting services for regulatory submissions.

Bottom Line

Jill Fiedler-Kelly's recent share purchase highlights insider confidence in Simulations Plus, Inc. Investors often track insider transactions for potential insights into company prospects. This activity, along with institutional moves, provides a snapshot of market sentiment towards SLP. Remember, insider transactions are reported after the fact and may not reflect current positions.